Long-Term Monitoring of Patients With Persistent Atrial Fibrillation After Pulsed Field Ablation.

IF 1.3 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Pace-Pacing and Clinical Electrophysiology Pub Date : 2025-05-01 Epub Date: 2025-04-02 DOI:10.1111/pace.15185
Wentao Li, Xianjin Hu, Fanghui Li, Yao Tong, Aobo Gong, Ying Cao, Zexi Li, Wenzhai Cao, Dayong Zhang, Min Xu, Xuechuan Dan, Kui Li, Rongzheng Yue, Kaijun Cui, Hongde Hu, Hua Fu, Rui Zeng
{"title":"Long-Term Monitoring of Patients With Persistent Atrial Fibrillation After Pulsed Field Ablation.","authors":"Wentao Li, Xianjin Hu, Fanghui Li, Yao Tong, Aobo Gong, Ying Cao, Zexi Li, Wenzhai Cao, Dayong Zhang, Min Xu, Xuechuan Dan, Kui Li, Rongzheng Yue, Kaijun Cui, Hongde Hu, Hua Fu, Rui Zeng","doi":"10.1111/pace.15185","DOIUrl":null,"url":null,"abstract":"<p><p>Most studies have followed patients with persistent atrial fibrillation (PeAF) using 12-lead or 24-h Holter electrocardiography, but this may overestimate the effectiveness of pulsed field ablation (PFA) in the treatment of PeAF. This study aimed to investigate the feasibility of PFA in patients with PeAF and follow-up using insertable cardiac monitoring that can provide information on the actual status of atrial arrhythmia (AA) recurrence after PFA. We prospectively enrolled 49 patients with PeAF who underwent PFA strategy comprising superior vena cava isolation, pulmonary vein isolation, and posterior wall box isolation between December 2022 and January 2024. After median follow-up of 14.1 months, 30 patients (61.22%) had zero AA burden. Kaplan-Meier analysis show that the freedom from recurrence increased with arrhythmia duration thresholds, from 59.54% to 80.50% (duration < 2 min vs. duration > 48 h, p = 0.040). Safety events occurred in two patients (one transient ischemic attack and one pseudoaneurysm). PFA is an effective modality for the treatment of patients with PeAF.</p>","PeriodicalId":54653,"journal":{"name":"Pace-Pacing and Clinical Electrophysiology","volume":" ","pages":"547-556"},"PeriodicalIF":1.3000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pace-Pacing and Clinical Electrophysiology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1111/pace.15185","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/2 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Most studies have followed patients with persistent atrial fibrillation (PeAF) using 12-lead or 24-h Holter electrocardiography, but this may overestimate the effectiveness of pulsed field ablation (PFA) in the treatment of PeAF. This study aimed to investigate the feasibility of PFA in patients with PeAF and follow-up using insertable cardiac monitoring that can provide information on the actual status of atrial arrhythmia (AA) recurrence after PFA. We prospectively enrolled 49 patients with PeAF who underwent PFA strategy comprising superior vena cava isolation, pulmonary vein isolation, and posterior wall box isolation between December 2022 and January 2024. After median follow-up of 14.1 months, 30 patients (61.22%) had zero AA burden. Kaplan-Meier analysis show that the freedom from recurrence increased with arrhythmia duration thresholds, from 59.54% to 80.50% (duration < 2 min vs. duration > 48 h, p = 0.040). Safety events occurred in two patients (one transient ischemic attack and one pseudoaneurysm). PFA is an effective modality for the treatment of patients with PeAF.

脉冲场消融后持续性心房颤动患者的长期监测。
大多数研究使用12导联或24小时动态心电图对持续性心房颤动(PeAF)患者进行随访,但这可能高估了脉冲场消融(PFA)治疗PeAF的有效性。本研究旨在探讨PFA在PeAF患者中的可行性,并使用可插入心脏监护仪进行随访,该监护仪可以提供PFA后心房心律失常(AA)复发的实际情况。我们前瞻性地招募了49例PeAF患者,他们在2022年12月至2024年1月期间接受了PFA策略,包括上腔静脉隔离、肺静脉隔离和后壁盒隔离。中位随访14.1个月后,30例患者(61.22%)AA负担为零。Kaplan-Meier分析显示,随着心律失常持续时间阈值的增加,复发率增加,从59.54%增加到80.50%(持续时间< 2 min vs.持续时间bb0 48 h, p = 0.040)。2例患者发生安全事件(1例短暂性脑缺血发作和1例假性动脉瘤)。PFA是治疗PeAF患者的一种有效方式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pace-Pacing and Clinical Electrophysiology
Pace-Pacing and Clinical Electrophysiology 医学-工程:生物医学
CiteScore
2.70
自引率
5.60%
发文量
209
审稿时长
2-4 weeks
期刊介绍: Pacing and Clinical Electrophysiology (PACE) is the foremost peer-reviewed journal in the field of pacing and implantable cardioversion defibrillation, publishing over 50% of all English language articles in its field, featuring original, review, and didactic papers, and case reports related to daily practice. Articles also include editorials, book reviews, Musings on humane topics relevant to medical practice, electrophysiology (EP) rounds, device rounds, and information concerning the quality of devices used in the practice of the specialty.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信